Leading Companies Reinforcing Their Presence in the Peripheral Nerve Stimulators Market

The peripheral nerve stimulators market is poised for notable growth as advancements in technology and increasing awareness of non-drug pain management methods come into focus. With innovations and expanding applications in healthcare, this market is attracting attention from medical providers and device manufacturers alike. Let's explore the current market size, key drivers, leading companies, evolving trends, and important segments shaping this industry's future.

Projected Market Growth and Expansion in Peripheral Nerve Stimulators
The peripheral nerve stimulators market is expected to experience robust growth in the coming years, reaching a market size of $1.14 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 8.4%. Several factors are fueling this growth, including advances in implantable and percutaneous stimulator technologies and the wider use of transcutaneous electrical nerve stimulation (TENS) devices. Additionally, the rise of ambulatory surgical centers and physiotherapy clinics contributes to increased device adoption. There is also a growing preference for rechargeable and disposable neurostimulation products, alongside heightened awareness of pain management options beyond pharmaceuticals. Key trends anticipated during the forecast period include the adoption of AI-powered pain management systems, cloud-based patient monitoring for neurostimulation, development of implantable and rechargeable neurostimulators, integration of IoT-enabled nerve stimulation solutions, and the application of smart manufacturing techniques in peripheral nerve stimulator production.

Download a free report of the peripheral nerve stimulators market report:
https://www.thebusinessresearchcompany.com/report/peripheral-nerve-stimulators-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Corporations Driving the Peripheral Nerve Stimulators Market
Several prominent companies are at the forefront of the peripheral nerve stimulators industry. These include Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Nevro Corp., Saluda Medical Pty Ltd., Stimwave Technologies Incorporated, Bioness Inc., SPR Therapeutics Inc., Neuspera Medical Inc., NeuroMetrix Inc., BioElectronics Corporation, Soterix Medical Inc., STIM Systems, NeuroSigma Inc., Synapse Biomedical Inc., BioControl Medical, Cardionomic Inc., Aleva Neurotherapeutics SA, NeuroPace Inc., Nervonik Inc., NeuraStim Technologies Inc., NeuroPulse Systems Inc., NeuroStim Devices Inc., Peripheral NeuroSolutions Ltd, BlueWind Medical, PINS Medical, Neurimpulse, and Cala Health Inc.
In a significant move in November 2023, Boston Scientific Corporation acquired Relievant Medsystems Inc., a US-based company specializing in minimally invasive treatments for chronic vertebrogenic back pain, for roughly $850 million. This acquisition is aimed at strengthening Boston Scientific's pain management offerings by adding Relievant's spinal nerve stimulation technologies to its portfolio.

Emerging Innovations Shaping the Peripheral Nerve Stimulators Industry
Innovations in the peripheral nerve stimulators field are increasingly focused on ultra-miniaturized systems designed to improve patient comfort and treatment effectiveness while broadening therapeutic applications. These highly compact devices harness advanced technologies to enhance portability, functionality, and integration.
For instance, in April 2023, NeuSpera Medical Inc., a US-based implantable medical device manufacturer, received FDA clearance for its next-generation ultra-miniaturized system targeting chronic peripheral nerve pain. This novel device delivers precise electrical impulses without traditional leads, making it minimally invasive and reducing risks linked to lead-based stimulators. Its small size facilitates easier implantation with reduced tissue damage, promoting quicker recovery. Moreover, this micro-implant offers long-term pain relief by stimulating the specific nerve pathways involved in chronic pain, representing a significant advancement in peripheral nerve pain management.

View the full peripheral nerve stimulators market report:
https://www.thebusinessresearchcompany.com/report/peripheral-nerve-stimulators-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Key Segments Driving Market Development in Peripheral Nerve Stimulators
This report segments the peripheral nerve stimulators market on several bases:
1) Product Type: Transcutaneous, Percutaneous, Implantable
2) Device Category: Stimulators, Continuous Peripheral Nerve Block (CPNB) Catheters, Pain Pumps, Other Devices
3) Purchase Mode: Disposable Devices, Rechargeable Devices
4) Application Area: Hospitals, Physiotherapy Centers, Ambulatory Surgical Centers, Clinics, Other Applications

Further subcategories include:
- Transcutaneous devices such as TENS units and surface electrodes
- Percutaneous devices including single-needle, multi-needle, and radiofrequency stimulators
- Implantable devices comprising spinal cord stimulators (SCS), peripheral nerve stimulation (PNS) devices, and neurostimulator implants

Together, these product and application divisions highlight the broad scope and diversity of the peripheral nerve stimulators market, reflecting its potential for continued growth and innovation.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.